🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The AML18 Pilot Trial will evaluate the feasibility of three interventions ...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2011-04
Trial ID
NCT01236144
Treatments Being Tested
Lymphoma is one of the fastest growing malignancies in the world, with an a...
Status
Unknown
Location
Department of Hematology, Shandong Provincial Hospital
Start Date
2019-11-01
Trial ID
NCT04134247
Treatments Being Tested
Persistent ductus arteriosus (DA) is a common entity in the premature newbo...
Status
Unknown
Location
Hospital Universitario La Paz
Start Date
2017-02-20
Trial ID
NCT04282941
This study will assess the impact of 2-drug (DA) or 3-drug (IDA) regimens o...
Status
Completed
Location
Ministry of Health and Medical Services
Start Date
2017-10-18
Trial ID
NCT03352206
Treatments Being Tested
This randomized phase III trial studies rituximab when given together with ...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2005-05
Trial ID
NCT00118209
Treatments Being Tested
The DOLF Triple Drug Therapy for Lymphatic Filariasis study will determine ...
Status
Completed
Location
Ministere de la Sante Publique et de la Population
Start Date
2016-07
Trial ID
NCT02899936
Treatments Being Tested
This single-center, single-group, open-label study evaluated changes in men...
Status
Completed
Location
Instituto Palacios, Salud y Medicina de la Mujer
Start Date
2025-02-14
Trial ID
NCT07752641
Treatments Being Tested
Restless Legs Syndrome (RLS) is a common neurological disorder. Augmentatio...
Status
Completed
Location
University of Missouri Health Care
Start Date
2016-01
Trial ID
NCT02642315
Treatments Being Tested
Acute lymphoblastic leukemia (ALL) is characterized by the abnormal prolife...
Status
Recruiting
Location
Hospital General de México Dr. Eduardo Liceaga
Start Date
2025-07-23
Trial ID
NCT07258043
This regimen aims to become the first line treatment for peripheral T cell ...
Status
Completed
Location
City of Hope Cancer Center
Start Date
2018-11-07
Trial ID
NCT03586999
Treatments Being Tested